The Minister of Health, Prof. Isaac Adewole has reiterated the federal government’s support for local production of drugs and vaccines for the management and control of disease outbreak in Nigeria.
The Minister made this known when a delegation from the Glaxo SmithKline (GSK), led by the Vice President, Medical & Clinical Emerging Market, Anil Dutta paid him a courtesy call in Abuja recently.
Prof. Adewole said that the federal government through the Federal Ministry of Health would partner with GSK in areas such as production of local drugs and vaccines and capacity building.
He pointed out that the production of local vaccines would reduce the death rate that occurre during outbreak of diseases across the country, he urged GSK to key into the federal government’s agenda in the health sector. He said that the priority of the present administration is for all stakeholders in the health sector to share collective view and focus more on health care delivery to Nigerians.
The Head of the delegation, the Vice President, Medical & Clinical Emerging Market, Anil Dutta pledged that GSK would continue to provide technical and financial support in areas like production of local drugs and vaccines in the country.
In his remark, the Executive Secretary, National Primary Healthcare Development Agency (NPHCDA), Dr. Faisal Shuaib informed that the revitalization of 10,000 PHC policy of FMOH would benefit immensely from this collaboration, adding that it would ensure affordable and accessible drug and vaccines across the country.